ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 147 filers reported holding ASCENDIS PHARMA A/S in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $24,603,000 | +13.0% | 190,900 | +46.3% | 0.02% | 0.0% |
| Q4 2020 | $21,765,000 | +10.2% | 130,500 | +2.0% | 0.02% | 0.0% |
| Q3 2020 | $19,753,000 | +26.0% | 128,000 | +20.8% | 0.02% | +21.1% |
| Q2 2020 | $15,677,000 | +134.0% | 106,000 | +78.2% | 0.02% | +90.0% |
| Q1 2020 | $6,700,000 | -25.5% | 59,500 | -8.0% | 0.01% | 0.0% |
| Q4 2019 | $8,997,000 | +882.2% | 64,669 | +361.9% | 0.01% | +900.0% |
| Q1 2018 | $916,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |